• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

Cardiovascular

AstraZeneca is pleased to present healthcare professionals with a variety of cardiovascular resources for your informational purposes.The educational materials are intended to provide information that can assist you in forming your own clinical and treatment decisions.

  1. Congress Library
  2. Medications
  3. Disease Education
  4. Continuing Education
  5. Pipeline

pipeline

This page provides access to AstraZeneca presentations and posters shared during the congresses listed below. Content availability is subject to the timeliness and permissions outlined by respective congresses.

AHA 2025

American Heart Association

 

November 7 - 10, 2025

Visit website

 

 

EU-ATTR 2025

European ATTR Amyloidosis Meeting for Patients and Doctors – 5th

 

September 25 - 26, 2025

Visit website

 

 

AHA-HSS 2025

American Heart Association - Hypertension Scientific Sessions (AHA-HSS)

 

September 04 - 07, 2025

Visit website

 

 

ESC 2025

European Society of Cardiology

 

August 29 - September 1, 2025

Visit website

 

 

ESH 2025

European Society of Hypertension

 

May 23 - 26, 2025

Visit website

 

 

ESC-HF HFA 2025

European Society of Cardiology-Heart Failure: Heart Failure Association

 

May 17 - 20, 2025

Visit website

 

 

ACC 2025

American College of Cardiology

 

March 29 - 31, 2025

Visit website

 

 

AHA 2024

American Heart Association (AHA 2024)

 

November 16 - 18, 2024

Visit website

 

 

  • ANDEXXA<sup>®</sup> (coagulation factor Xa (recombinant), inactivated-zhzo) Lyophilized powder for solution for intravenous injection
  • BRILINTA<sup>®</sup> (ticagrelor) Tablets
  • CRESTOR<sup>®</sup> (rosuvastatin calcium) Tablets
  • FARXIGA<sup>®</sup> (dapagliflozin) Tablets
  • WAINUA<sup>™</sup> (eplontersen)
  • Other Cardiovascular Diseases Explore Other Cardiovascular Diseases
  • Transthyretin-mediated Amyloidosis (ATTR) Explore Transthyretin-mediated Amyloidosis (ATTR)

Email Recipient

  1. Colleague
  2. Myself

e-Learning

Addressing Challenges: Best Practices for DOAC Reversal in Intracranial Hemorrhage

Voxmedia LLC

15-Oct-2024 to 31-Oct-2025

Online enduring material

Learn More

e-Learning

ACC.25 Spotlight Session

American College of Cardiology Foundation

18-Apr-2025 to 18-Apr-2026

Meeting on Demand 

Learn More

e-Learning

Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

Voxmedia LLC

13-Dec-2024 to 13-Dec-2025

Online enduring material

Learn More

e-Learning

Best Practices for Managing Hyperkalemia in Patients with Heart Failure and Chronic Kidney Disease

Voxmedia LLC

30-May-2025 to 30-May-2026

On-Demand 1.5 hour video enduring material

Learn More

 

 

e-Learning

Podcast

Association of Black Cardiologists, Inc.

15-Nov-2024 to 15-Nov-2025

CME Enduring Podcast 

Learn More

e-Learning

Webcast

Association of Black Cardiologists, Inc.

25-Nov-2024 to 24-Nov-2025

CME Enduring Webcast

Learn More

e-Learning

Deep Dive into Five

Association of Black Cardiologists, Inc.

01-Dec-2024 to 01-Dec-2025

Webcast/Podcast review live program information

Learn More

e-Learning

Enduring Webcast

National Association For Continuing Education, LLC

29-Aug-2025 to 28-Aug-2026

Enduring CME Webcast

Learn More

e-Learning

TTRansforming the TTReatment of ATTR: Pathophysiology, Diagnosis, and Emerging Treatment Strategies for Hereditary Transthyretin Cardiac Amyloidosis

PVI, PeerView Institute for Medical Education, Inc.

24-Oct-2024 to 23-Oct-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

Request a field medical follow-up

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am not a healthcare professional practicing in the United States (Take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2025 AstraZeneca. All rights reserved.

US-69609; US-91816; US-103094; US-106788

Last Updated 11/25

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Consumer Health Data Privacy Notice

Privacy Notice

Legal Notice

Cookie Preferences

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Survey Feedback

Your Privacy Choices

Consumer Health Data Privacy Notice

Pharma Logo

Privacy NoticeLegal NoticeCookie Preferences